AURELIE PLESSIER, Mdphd

Biography

Dr. Aurélie Plessier is a French hepatologist and consultant in the Hepatology Unit at Beaujon Hospital (Clichy, France), where she has been leading the National Referral Centre for Vascular Liver Diseases (CRMVF) since 2006. She is internationally recognized for her expertise in vascular disorders of the liver and portal hypertension.

She holds a PhD in Physiology and Pathophysiology from Paris Cité University (2021), alongside her medical degree (MD in Hepatology and Gastroenterology, Paris University, 2000), and postgraduate degrees in Biostatistics and Medical Ethics.

Dr. Plessier is actively involved in both clinical care and research. Her scientific interests focus on splanchnic vein thrombosis, non-cirrhotic portal hypertension, and vascular complications of rare liver diseases. She has led or contributed to numerous national and international multicentre studies and has authored high-impact publications in leading hepatology journals.

She has played a key role in developing guidelines on vascular liver diseases, having coordinated the national AFEF guidelines and contributed to Baveno and EASL international recommendations. She serves on the Steering Committee of VALDIG (Vascular Liver Disease Interest Group) and on the Scientific Committee of ERN Rare Liver.

In addition to her clinical and research activities, Dr. Plessier is responsible for coordinating the French national network FILFOIE, which connects stakeholders across rare liver diseases, a strategic program aimed at improving disease understanding, patient care, and healthcare pathways for rare liver conditions.

She also serves on the Steering Committee of the French Association for the Study of the Liver (AFEF) and is a regular peer reviewer for major journals, including Journal of Hepatology, Hepatology, Liver International, Liver Transplantation, and Annals of Internal Medicine.

A mother of four, Dr. Plessier combines her deep commitment to academic medicine with leadership in collaborative networks dedicated to improving patient care in rare and complex liver diseases.